This graph depicts the medicine used in the treatment of African trypanosomiasis. The graph
shows that Melarsopro use as a treatment has been falling while Efiornithin use has been rising
over the years
A graph of treatment of cases in percentage of human african trypanosomiasis according to
medicine used from 2003-2008. 2008 is the lowest and 2006 as the highest.
Treatment of second stage cases of human african trypanosomiasis according to medicine used
from 2003 to 2008. The number of cases using melarsoprol has decreased during this time span
but eflornithine has increased.
In 2003- 2008 the number of cases of trypanosomiasis has fluctuated greatly. In 2003 with
80% having used melarsoprol and in 2008 60% having used this medicine.
This is a graph of the treatment of second-stage cases of human african trypanosomias according
to medicine used from 2003-2008. The medicines were Melarsoprol and eflornithine. Melarsoprol
seemed to work better since there were less cases each year under that drug.
Treatment of second-stage cases (%) of human African trypanosomiasis according to medicine
used for the period between 2003-2008. In the years 2003-2006 the drug Melarsoprol was the
predominant drug used for between approx. 82-92% and Efloomthin was used for approx. 10-20%
of patients. During 2007 and 2008, the use of Efloomthin increased to approx. 30-50%.
This chart shows the incidence and treatment of second-stage trypanosomiasis in Africa. It
shows how it is pretty high and the type of drugs used to treat it are changing
This image shows the percentages of treatment of second stage cases of human African trypanosomiasis
according to medicine used from 2003 to 2008. Two different medications are given a color
(blue and gray). Each of the six years is depicted by a bar. The bar is color coded by drug
and shows the percentage of each.
This chart describes treatment of second-stage cases (%) of human African trypanosomiasis
according to medicine used, for the years 2003 through to 2008.
This chart describes treatment of second-stage cases (%) of human African trypanosomiasis
according to medicine used, for the years 2003 through to 2008.
The graph shows the percentage of cases of different diseases from 2003-2008. The largest
disease is Melarsoprol making up over 80% of the data in 2003. It also decrease the great
in the 5 years the graph covers.
A bar graph showing treatment type percentages of 2nd stage human African panasomiasis in
years from 2003 to 2008. In 2003, a little over 80% were treated with metasoprol while less
than 20% were treated with Eformathine. This remained true through 2006, with the percentage
treated with metasoprol peaking in 2006 at roughly 90%. In 2007 a change began, with roughtly
25% treated with Eformathine and in 2008 it was roughly 50% for each type of treatment.
This graph charts the use of drugs used to treat second stage Trypanosomiasis. From 2003 to
2006, use of Melarsoprol was highly predominant. In 2007 and 2008, Eflornithine became more
prominent, used approximately 50% of the time by 2008.
the graph describes what medicine was used to treat African trypanosomiasis during the years
of 2003-2008. The 2 medicines are named melarsoprol and efiornithine. In 2003 melarsoprol
was used to treat 80% of cases. The use of melarsoprol goes down to 50% in 2008
